Trials / Terminated
TerminatedNCT02762487
RELIEF Europe Study
RELIEF Europe Study. A Prospective, Multicenter Study of RefluxManagement With the LINX® System for Gastroesophageal Reflux Disease After Laparoscopic Sleeve Gastrectomy
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 7 (actual)
- Sponsor
- Torax Medical Incorporated · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the LINX device in patients who have previously undergone laparoscopic sleeve gastrectomy (LSG) for obesity and have chronic gastroesophageal reflux disease (GERD). The study will monitor safety and changes in reflux symptoms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | The LINX® Reflux Management System | The LINX device is a permanent implant placed at the area of the lower esophageal sphincter (LES) and is designed to augment a weak LES and minimize or eliminate GERD-related symptoms. |
Timeline
- Start date
- 2015-11-01
- Primary completion
- 2017-02-01
- Completion
- 2017-02-01
- First posted
- 2016-05-05
- Last updated
- 2017-10-16
Locations
4 sites across 2 countries: Germany, Italy
Source: ClinicalTrials.gov record NCT02762487. Inclusion in this directory is not an endorsement.